Pivotal Study

Usually, a Phase III study which presents evidence-based data that the FDA will rely on when deciding whether or not to approve a drug or device. A pivotal study will generally be well-controlled, randomized, statistically powered to adequate size, and whenever possible, double-blind. It represents the optimized drug or device as intended for commer­cialization, along with the final packaging and labeling to be evaluated in the targeted population.